ProShare Advisors’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $180K | Sell |
|
|||||
|
2025
Q2 | $212K | Buy |
|
|||||
|
2025
Q1 | $199K | Sell |
|
|||||
|
2024
Q4 | $189K | Buy |
|
|||||
|
2024
Q3 | $255K | Buy |
|
|||||
|
2024
Q2 | $382K | Sell |
|
|||||
|
2024
Q1 | $379K | Buy |
|
|||||
|
2023
Q4 | $324K | Buy |
|
|||||
|
2023
Q3 | $75.4K | Buy |
|
|||||
|
2023
Q2 | $118K | Buy |
|
|||||
|
2023
Q1 | $69.8K | Sell |
|
|||||
|
2022
Q4 | $221K | Buy |
|
|||||
|
2022
Q3 | $212K | Buy |
|
|||||
|
2022
Q2 | $150K | Sell |
|
|||||
|
2022
Q1 | $304K | Sell |
|
|||||
|
2021
Q4 | $431K | Sell |
|
|||||
|
2021
Q3 | $899K | Buy |
|
|||||
|
2021
Q2 | $1.23M | Buy |
|
|||||
|
2021
Q1 | $558K | Sell |
|
|||||
|
2020
Q4 | $316K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $132K | Sell |
|
|||||
|
2018
Q2 | $112K | Sell |
|
|||||
|
2018
Q1 | $158K | Sell |
|
|||||
|
2017
Q4 | $212K | Buy |
|
|||||
|
2017
Q3 | $257K | Buy |
|
|||||
|
2017
Q2 | $341K | Sell |
|
|||||
|
2017
Q1 | $163K | Sell |
|
|||||
|
2016
Q4 | $327K | Buy |
|
|||||
|
2016
Q3 | $417K | Sell |
|
|||||
|
2016
Q2 | $392K | Buy |
|
|||||
|
2016
Q1 | $501K | Sell |
|
|||||
|
2015
Q4 | $1.15M | Buy |
|